Totally Implantable Venous Access Port Infection in Northwest of Iran

Dawood Aghamohammadi; Solmaz Fakhari; Eissa Bilehjani; Yahya Ataei; Marzie Jafari

E-ISSN : 2148-9696

Crescent Journal of
Medical and Biological Sciences

Main Page Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jul 2017, Vol 4, Issue 3

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
Totally Implantable Venous Access Port Infection in Northwest of Iran
Dawood Aghamohammadi¹, Solmaz Fakhari², Eissa Bilehjani³, Yahya Ataei⁴, Marzie Jafari⁵
¹Associated Professor in Anesthesiology, Fellowship in Palliative Care Medicine, Pain and Palliative Care Department, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran ²Assistant Professor in Anesthesiology, Fellowship in Palliative Care Medicine, Pain and Palliative Care Department, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran ³Assistant Professor in Anesthesiology, Anesthesiology Department, Madani Hospital, Tabriz University of Medical Sciences, Tabriz, Iran ⁴Anesthesiologist, Fellowship in Palliative Care Medicine, Pain and Palliative Care Department, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran ⁵MD, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
CJMB 2017; 4: 126–130 Viewed : 3426 times Downloaded : 3094 times. Keywords : Totally implantable venous access port, Chemotherapy, Infection, Complication, Cancer
Full Text(PDF) \| Related Articles
Abstract

Objectives: The totally Implantable Venous Access Ports (TIVAPs) are widely used for chemotherapy, parenteral nutrition, blood sampling, infusion or injection. They are suitable for long-term use and improve the patient"s quality of life; however they have some important complications. One of the most common complications is infection. We investigated the port infection rate as well as its risk factors. Materials and Methods: All patients with TIVAP who were admitted to the academic palliative care clinic for heparin flash, Haber needling or care of TIVAP, were enrolled in study. Patients" demographic, sociodemographic data and clinical signs and symptoms were collected by questionnaire and physical exam. Blood culture was performed from port access of patients. The port removed in any case with positive blood culture or other irresolvable problem. The collected data were compared between patients with or without port infection. Results: Out of 116 patients, 95 patients (81.9%) were female and 21 patients (18.1%) were male. The rate of infection was 5.2%. In 11 cases the port was removed during the study period. The total complication rate was 15.5%. There were not any correlations between type of malignancy, patients" level of education, previous chemotherapy and radiation therapy and the length of time of port implantation with port infection rate. Conclusions: The prevalence of the infection and total complication rate was 15.5%. and 5.2% respectively. Infection with Staphylococcus aureus was the most common reason.